IHE Life Sciences SME Market Access Program

With funding support from the federal government, and the Alberta Ministry of Jobs, Economy and Innovation, the Institute of Health Economics (IHE) is pleased to release a Call for Expressions of Interest (see link below) from organizations that would like to participate in a project intended to strengthen their market access opportunity.  

The project will support Alberta-based life sciences companies with promising, market-ready healthcare technology that are currently seeking market access in Alberta or beyond.  Support will include the development of an economic model to quantify the business case for procurement, as well as an Evidence Development Plan to guide collection of data from on-market routine clinical use in order to strengthen the economic evidence and support further market access opportunities.    

Interested organizations are encouraged to download and review the Call for Expressions of Interest and submit their response by September 21, 2020 to [email protected].

Please note that we will not have capacity for individual company meetings prior to Advisory Group shortlisting following receipt of Expressions of Interest.  Please send in any questions that you have to [email protected] and we will do our best to provide a response, and then post responses for other interested companies to review on this webpage, see below. (so please check back regularly for updates).

Contact:

Dan Palfrey Director, Industry Partnerships [email protected] 

Downloads

Call for Expressions of Interest (attached).

 

Questions and Answers: (IHE is posting answers below to questions we are receiving from potential applicants)

Question: What is the process following submission of the EOI for selected SMEs?  

Answer: The IHE will review the EOIs, prepare summary overviews, and will present to an Advisory Group that will help guide SME selection.  From there, IHE will engage with the SMEs to further understand the EOI, and will initiate the project with them via execution of a Service Agreement. 

Question: What kind of real-world data does the SME need to bring into the project and will IHE assist the SME in additional opportunities to collect the required data to complete the model? 

Answer: IHE will prepare an Evidence Development Plan that will inform the SME and the procuring health system of the data to collect. There is no need to bring in real world data at project initiation.

Question: What is the estimated time required on the part of the IHE during each phase of the project? 

Answer: From project kick-off, 5 months for the model and Evidence Development Plan, and several months for the model update following receipt of data.